• DRINABANT chembl:CHEMBL3545166

    Alternate Names:

    AVE-1625
    DRINABANT

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antiobesity agent,for treatment for Alzheimer's disease
    (0 More Sources)

    Publications:

  • Interaction Score: 3.86

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Cannabinoid CB1 receptor antagonist
    Novel drug target Established target

    PMIDs:
    None found